A More Aggressive FTC Is Starting to Target Drug Mergers and Industry Middlemen | Local News
Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal Trade Commission is moving against drug companies and
Stay updated with breaking news from Dave Ricks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal Trade Commission is moving against drug companies and
During the recently concluded session of the Indiana General Assembly, lawmakers passed new reading initiatives, added limits to high-school graduation waivers, and increased post-secondary education support.
Industry analysts are skeptical that Federal Trade Commission Chair Lina Khan can win her first fight against a drug industry merger. It will be reviewed by a judge appointed by President Donald Trump.
Industry analysts are skeptical that Federal Trade Commission Chair Lina Khan can win her first fight against a drug industry merger. It will be reviewed by a judge appointed by then-President Donald Trump.
Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal Trade Commission is moving against drug companies and industry middlemen as part of the Biden administration's push for lower drug prices at the pharmacy counter.